Joaquin Duato

Last updated
Joaquin Duato
JnJ Duato cropped.jpg
Born1962 (age 62–63)
Spain
CitizenshipSpain
U.S.
Education ESADE Business School (MBA)
Thunderbird School of Global Management
OccupationBusinessman
Years active1989-present
TitleChairman and CEO of Johnson & Johnson
Term2022-present
Children2

Joaquin Duato (born April 1962) is a Spanish-American business executive. He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate. [1] He is the company's eighth CEO since it became a publicly-traded company in 1944. In 2023, Duato received $28.4 million, the highest paid CEO of any major US pharmaceutical company.

Contents

Early life and education

Duato grew up in Valencia, Spain. His career in health care was influenced by his family. His mother was a nurse, his grandfather was a pediatrician, and his grandmother a pharmacist. [2] Duato speaks English, Spanish, and Italian. He received a Master of Business Administration from ESADE Business School in Barcelona, Spain, and a Master of International Management from the Thunderbird School of Global Management in Phoenix, Arizona. [3] Duato is a dual citizen of Spain and the US. [4]

Career

In 1989, Duato began his career with Johnson & Johnson, joining Janssen Pharmaceuticals in Spain. [2] [5] After moving to the US in 2002, Duato was appointed executive vice president, worldwide chairman, pharmaceuticals in 2011. His growth strategy led to the turnaround of Johnson & Johnson’s struggling pharmaceutical business in the early 2000s. [3]

In 2018 when he was promoted to vice chairman of Johnson & Johnson’s executive committee, he led the pharmaceuticals and consumer product divisions and oversaw supply-chain and technology operations. [5] [6] He also was interim Chief Information Officer. [3]

Duato was appointed CEO in August 2021 which became effective in January 2022. He was also appointed to the company’s board of directors. [7] [8] In November 2022, he was elected chairman, effective January 2023. Duato oversaw the separation of Johnson & Johnson's consumer health segment, now an independent publicly traded company, Kenvue. [9] During this time, Duato was the executive sponsor of the company's African Ancestry Leadership Council. [10]

In 2023, Duato was the highest paid CEO of the major pharmaceutical companies, earning $28.4 million, a 117% increase over 2022. [11]

Board membership and honors

In recognition of his efforts, Duato was named a Healthcare Businesswomen's Association Honorable Mentor honoree in 2017. [12] In 2021, Duato was ranked #3 on the NJBIZ Manufacturing Power 50 list. [13] The following year, Duato received the 2022 ESADE Award for his leadership with Johnson & Johnson. [14] [15] In 2023 Duato was bestowed with the Order of Civil Merit, Commander by Number, by King Felipe VI of Spain. [16] [17] He is also a member of the Business Roundtable. [16]

Duato has been on the boards of the United States-Spain Council, UNICEF USA, Tsinghua University School of Pharmaceutical Sciences, and the Hess Corporation. [18] [6] He was chair of Pharmaceutical Research and Manufacturers of America from 2017 to 2018. [19] [20]

Personal life

Duato is married, with two adult children, and lives in Pennsylvania. [21]

References

  1. ↑ Nathan-Kazis, Josh. "J&J's CEO Plans to Step Down. Analysts Expect a Smooth Transition". www.barrons.com. Retrieved 2022-07-06.
  2. 1 2 "5 Things to Know About Johnson & Johnson's New CEO Joaquin Duato". 16 June 2023. Retrieved 2023-06-16.
  3. 1 2 3 "The Architect of J&J's Breakup Bets on Tech for the Future of Drugs". Bloomberg.com. 2022-04-29. Retrieved 2022-06-15.
  4. ↑ Rosenbaum, Eric (2022-03-30). "Next decade will transform health care more than past century: Johnson & Johnson CEO". CNBC. Retrieved 2022-06-15.
  5. 1 2 "A Look Inside J&J's Partnering & Innovation-Building Model". www.lifescienceleader.com. Retrieved 2022-06-15.
  6. 1 2 "J&J CEO Steps Down, Taps Successor Joaquin Duato". BioSpace. Retrieved 2022-06-15.
  7. ↑ Griffin, Riley (2021-08-19). "J&J's New Insider CEO Brings Expertise From Crucial Pharma Post". Bloomberg.com. Retrieved 2022-06-15.
  8. ↑ "Johnson & Johnson adds vice chairman to leadership". nj. Associated Press. 2010-12-15. Retrieved 2022-06-15.
  9. ↑ "J&J CEO Joaquin Duato discusses how he leads during challenging times and why the next decade will be the golden era for health innovation". Fortune. Retrieved 2023-11-17.
  10. ↑ Rivas, Kayla (2021-08-20). "J&J's new CEO Joaquin Duato: What to know". FOXBusiness. Retrieved 2023-11-17.
  11. ↑ Dunleavy, Kevin (2024-03-13). "J&J's Joaquin Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings". fiercepharma.com. Retrieved 2024-12-30.
  12. ↑ "2017 Joaquin Duato". Healthcare Businesswomen's Association. 2017. Retrieved 2024-12-30.
  13. ↑ "Presenting the 2021 Manufacturing Power 50". NJBIZ. 2021-12-13. Retrieved 2022-06-15.
  14. ↑ "Joaquín Duato, CEO of Johnson & Johnson, to Receive Esade Award". www.esade.edu. 2022-06-14. Retrieved 2023-11-17.
  15. ↑ "Future, Inspiration and Lots of Networking at the 26th Esade Alumni Annual Meeting in Barcelona". www.esadealumni.net. Retrieved 2023-11-17.
  16. 1 2 "Joaquin Duato". www.businessroundtable.org. Retrieved 2024-12-28.
  17. ↑ "Joaquin Duato". JNJ.com. Retrieved 2024-12-28.
  18. ↑ "Members". U.S. Spain Council. Retrieved 2024-12-28.
  19. ↑ "Joaquin Duato Named PhRMA Board Chairman". Johnson & Johnson. 2017-01-09. Retrieved 2024-12-30.
  20. ↑ "Amgen CEO Robert A. Bradway Becomes PhRMA Board Chairman". Pharmaceutical Research and Manufacturers of America. 2018-02-07. Retrieved 2024-12-30.
  21. ↑ "Joaquin Duato Council for Inclusive Capitalism" . Retrieved 2024-12-12.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.